↓ Skip to main content

Editorial: vedolizumab as a treatment and cause of extra‐intestinal manifestations of inflammatory bowel disease

Overview of attention for article published in Alimentary Pharmacology & Therapeutics, January 2018
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
13 Mendeley